The design of cereblon-binding molecular glues (MGs) that selectively recruit a desired protein while excluding teratogenic SALL4 is an area of significant interest when designing therapeutic agents. Previous studies show that SALL4 is degraded in the presence of IKZF1 degraders pomalidomide, and to a lesser extent by CC-220. To expand our understanding of the molecular basis for the interaction of SALL4 with cereblon, we performed biophysical and structural studies demonstrating that SALL4 zinc finger domains one and two (ZF1-2) interact with cereblon (CRBN) in a unique manner. ZF1 interacts with the N-terminal domain of cereblon and ZF2 binds as expected in the C-terminal IMiD-binding domain. Both ZF1 and ZF2 contribute to the potency of ...
The immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide, all approved for the...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Cereblon, a primary target of thalidomide and its derivatives, has been characterized struc-turally ...
The design of cereblon-binding molecular glues (MGs) that selectively recruit a desired protein whil...
Although several proteins are known to interact with cereblon in the presence of molecular glues (MG...
The small molecule drugs thalidomide, lenalidomide, and pomalidomide induce ubiquitination and prote...
Cereblon (CRBN) is the substrate receptor of the CRL4CRBN E3 ubiquitin ligase and is a central playe...
The protein cereblon serves as a substrate receptor of a ubiquitin ligase complex that can be tuned ...
The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 lig...
Dissertation ist gesperrt bis 31. Dezember 2024 !The infamous teratogenic small molecule thalidomide...
Thalidomide analogues (or immunomodulatory imide drugs, IMiDs) are cornerstones in the treatment of ...
AbstractThalidomide and its derivatives lenalidomide and pomalidomide are important anticancer agent...
Cereblon (CRBN) is a ubiquitously expressed E3 ligase substrate receptor and a key player in pharmac...
To expand the chemical toolkit for targeted protein degradation, we report the generation of a new s...
Thalidomide and its derivatives lenalidomide and pomalidomide are important anticancer agents but ca...
The immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide, all approved for the...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Cereblon, a primary target of thalidomide and its derivatives, has been characterized struc-turally ...
The design of cereblon-binding molecular glues (MGs) that selectively recruit a desired protein whil...
Although several proteins are known to interact with cereblon in the presence of molecular glues (MG...
The small molecule drugs thalidomide, lenalidomide, and pomalidomide induce ubiquitination and prote...
Cereblon (CRBN) is the substrate receptor of the CRL4CRBN E3 ubiquitin ligase and is a central playe...
The protein cereblon serves as a substrate receptor of a ubiquitin ligase complex that can be tuned ...
The drugs lenalidomide and pomalidomide bind to the protein cereblon, directing the CRL4–CRBN E3 lig...
Dissertation ist gesperrt bis 31. Dezember 2024 !The infamous teratogenic small molecule thalidomide...
Thalidomide analogues (or immunomodulatory imide drugs, IMiDs) are cornerstones in the treatment of ...
AbstractThalidomide and its derivatives lenalidomide and pomalidomide are important anticancer agent...
Cereblon (CRBN) is a ubiquitously expressed E3 ligase substrate receptor and a key player in pharmac...
To expand the chemical toolkit for targeted protein degradation, we report the generation of a new s...
Thalidomide and its derivatives lenalidomide and pomalidomide are important anticancer agents but ca...
The immunomodulatory drugs (IMiDs) thalidomide, lenalidomide, and pomalidomide, all approved for the...
Upon binding to thalidomide and other immunomodulatory drugs, the E3 ligase substrate receptor cereb...
Cereblon, a primary target of thalidomide and its derivatives, has been characterized struc-turally ...